Liquid Biopsy

Liquid biopsy is a non-invasive diagnostic and monitoring method that obtains tumor-related information from a patient's bodily fluids, such as blood, urine, or saliva. It is widely utilized for patient convenience during cancer screening processes that require multiple tests.

Specifically, liquid biopsy that analyzes circulating tumor cells (CTCs) from blood provides highly accurate information about cancer.

Why Liquid Biopsy?

By obtaining patient fluids in a simple and safe manner, advanced analysis of collected CTCs becomes possible, ultimately improving patients' quality of life.

Tissue biopsy is not an option when

Circulating tumor cells (CTCs)

Circulating Tumor Cells (CTCs) are cancer cells that have detached from a primary tumor or metastatic site and enter the peripheral blood circulation. These cells enter blood vessels or lymphatic vessels and circulate through the body, ultimately accelerating cancer development and inducing metastasis, which is a major cause of decreased survival rates in cancer patients.

CTCs: The Cause of Cancer Metastasis

CTC analysis

This service analyzes specific biomarker expression and genes in circulating tumor cells (CTCs) for prognosis assessment and precision medicine.

Intellectual Property